Reno Caps are black oval softgel imprinted “z622”. These softgels provide water- soluble vitamins. : Each Reno Caps softgel contains: Vitamin C (Ascorbic Acid)………………………100 mg Thiamine (as thiamine mononitrate)……………..1.5 mg Riboflavin………………………………………..1.7 mg Niacin (as niacinamide)………………………….20 mg Vitamin B-6 (as pyridoxine… Continue Reading
The active ingredient inRenvela is sevelamer carbonate, a polymeric amine that binds phosphate and is meant for oral administration. It was developed as a pharmaceutical alternative to sevelamer hydrochloride (Renagel). Sevelamer carbonate is an anion exchange resin, with the same… Continue Reading
Rifabutin Capsules USP for oral administration contain 150 mg of the rifamycin antimycobacterial agent rifabutin, USP, per capsule, along with the inactive ingredients crospovidone, gelatin, iron oxide red, magnesium stearate, microcrystalline cellulose, potassium hydroxide, shellac, silicon dioxide, sodium lauryl sulphate,… Continue Reading
Rivastigmine transdermal system contains rivastigmine, a reversible cholinesterase inhibitor known chemically as (S)-3-[1-(dimethylamino) ethyl]phenyl ethylmethylcarbamate. It has an empirical formula of CHNO as the baseand a molecular weight of 250.34 (as the base). Rivastigmine is a viscous, clear, and colorless… Continue Reading
Lidocaine 2.5% and Prilocaine 2.5%, a topical anesthetic agent, is an emulsion in which the oil phase is a eutectic mixture of lidocaine and prilocaine in a ratio of 1:1 by weight. This eutectic mixture has a melting point below… Continue Reading
Lidocaine 2.5% and Prilocaine 2.5%, a topical anesthetic agent, is an emulsion in which the oil phase is a eutectic mixture of lidocaine and prilocaine in a ratio of 1:1 by weight. This eutectic mixture has a melting point below… Continue Reading
Repaglinide Tablets, USP (repaglinide) are an oral blood glucose-lowering drug of the meglitinide class used in the management of type 2 diabetes mellitus (also known as non-insulin dependent diabetes mellitus or NIDDM). Repaglinide, S(+)2-ethoxy-4(2((3-methyl-1-(2-(1-piperidinyl) phenyl)-butyl) amino)-2-oxoethyl) benzoic acid, is chemically… Continue Reading
Risedronate sodium delayed-release tablets contain a pH-sensitive enteric coating and a chelating agent (EDTA). Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Risedronate sodium tablet for oral administration contains the equivalent of 35 mg of… Continue Reading
Purpose Skin Protectant Topical Anesthetic Skin Protectant
Purpose Skin Protectant Topical Anesthetic Skin Protectant
